Compiled by the editorial desk with reference to expert commentary from NYU School of Medicine and statements reported by Futurism.

Italian surgeon Sergio Canavero has again made headlines by claiming he performed the world's first human head transplant, this time on corpses. But medical ethicists and transplant specialists are pushing back, calling the assertions scientifically baseless and potentially harmful to patients and the field of medicine.

Arthur Caplan, founding head of the division of medical ethics at NYU School of Medicine, told Futurism that the idea of a head transplant is "ludicrous" to researchers who work daily with complex transplant procedures. Caplan, who also leads a team working on face transplants at NYU, noted that even those operations are difficult to make successful. "We can barely keep the face from being rejected, much less all the tissues of the head," he said.

Canavero, who has promoted the concept for over two years, claims his recent work on corpses demonstrates the ability to attach nerves and blood vessels. However, Caplan argues that such a demonstration falls far short of a viable medical procedure. He compared Canavero's approach to "unscrewing a bulb from a socket and putting in a new one," ignoring the complex chemistry and neural inputs that a new brain would face. Even if a patient could survive the surgery—which Caplan doubts due to immune rejection—he believes the brain would be unable to process the new environment, leaving the person "insane."

Ethical and Scientific Concerns

Caplan is not alone in his skepticism. He points out that Canavero has not provided evidence of successful spinal cord reconnection in animal studies. While Canavero has performed surgeries on monkeys and rats, he has not kept the animals alive or conscious for any significant period. In the monkey procedure, there was no attempt to reconnect the spinal cord, meaning the subject would have been paralyzed if it had survived.

The broader scientific community also suffers from such claims, according to Caplan. "It's despicable and dangerous for real science," he said, noting that Canavero has "set up shop in China because no one else in the world has any credence in what he's doing." Caplan emphasized that Canavero has not demonstrated his techniques in animals, and there is no reason to believe they would work in humans.

Caplan also warned that sensational announcements by press release, rather than peer-reviewed research, cast doubt on the trustworthiness of mainstream scientists. "People believe that scientists who are using powerful technologies will just screw around with them," he said, adding that such claims can make the public wary of legitimate research.

False Hope for Patients

One of the most troubling aspects, Caplan said, is the false hope Canavero offers to people with paralysis or terminal illnesses. "There are people out there with paralyzed bodies, and people dying of terrible diseases, who think, 'maybe I could transplant my head,'" he said. "It's cruel to them, and then they kind of get angry with disappointment when the technology doesn't deliver."

Instead of pursuing head transplants, Caplan suggests that Canavero should focus on spinal cord regeneration, a field with far greater potential impact. "If he did know how to make the spinal cord regenerate, there are literally millions of people worldwide with damaged and severed spinal cords," he explained. "Instead of yammering on incessantly about head transplants, if he had something to help them, he should be using it with them."

Caplan does not foresee a successful head transplant in the near future, if ever. He believes that regenerative medicine and artificial intelligence research are more likely to yield practical advances. In the meantime, he compares head transplant hype to archaic procedures like purging and leeching, which were once accepted but later abandoned.

The controversy underscores the ethical responsibilities of scientists and doctors who push the boundaries of medicine. Misrepresenting the scope of one's work can harm not only peers but also the very patients the research aims to help.